Article | April 5, 2018

Insights Into Drug Delivery Device Manufacturing From Development Through Commercialization

Source: SMC Ltd.

By Sheleagh Dougan and Meredith Canty, SMC Ltd.


Biologics and other targeted therapy techniques are creating opportunities for innovative device solutions that meet the needs of specific patient groups. As these therapies often require low annual volumes, the associated device manufacturing strategy must also fit commercial expectations, even at those volumes. Optimal manufacturing solutions should be identified to meet the quality, financial, timeline, and patient needs of the product. Download this paper for an overview of insights into drug delivery device manufacturing from development through commercialization.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Delivery Leader? Subscribe today.

Subscribe to Drug Delivery Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Drug Delivery Leader